Cargando…
Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
An increased understanding of the interactions between the immune system and tumors has opened the door to immunotherapy for cancer patients. Despite some success with checkpoint inhibitors including ipilimumab, pembrolizumab, and nivolumab, most cancer patients remain unresponsive to such immunothe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983580/ https://www.ncbi.nlm.nih.gov/pubmed/29724044 http://dx.doi.org/10.3390/ijms19051340 |